Market Cap 45.11M
Revenue (ttm) 0.00
Net Income (ttm) -83.74M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.09
Volume 70,000
Avg Vol 211,704
Day's Range N/A - N/A
Shares Out 7.32M
Stochastic %K 68%
Beta 0.70
Analysts Hold
Price Target $6.00

Company Profile

Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases in the United States. The company's lead product candidate is zetomipzomib (KZR-616), a selective immunoproteasome inhibitor for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b/2 clinical trials in systemic lupus erythematosus. It is also developing KZR-261,...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 822 5600
Address:
4000 Shoreline Court, Suite 300, South San Francisco, United States
d_risk
d_risk Nov. 12 at 10:28 PM
$KZR - Kezar Life Sciences, Inc. - 10Q - Updated Risk Factors KZR’s latest 10-Q risk factors expand on capital needs, clinical trial and regulatory hurdles, strategic alternatives, restructuring uncertainties, IP and patent challenges, executive retention, cybersecurity, global volatility, concentrated ownership, and new compliance and anti-takeover risks. #Biotechnology #Cybersecurity #CapitalNeeds #RegulatoryRisk #ClinicalTrials 🟢 Added 🟠 Removed https://d-risk.ai/KZR/10-Q/2025-11-12
0 · Reply
Adrianople117
Adrianople117 Nov. 7 at 9:58 PM
$KZR possibly.... we will see with earnings how much cash they have now.
0 · Reply
Maddmike
Maddmike Nov. 7 at 9:06 PM
$KZR back to$5 🤔
0 · Reply
Adrianople117
Adrianople117 Nov. 4 at 6:28 PM
$KZR hmmm....
0 · Reply
Adrianople117
Adrianople117 Oct. 31 at 4:27 AM
$KZR hmmm.... first its ever dropped below 6... well have to see during market open what happens... curious
0 · Reply
brj1323
brj1323 Oct. 24 at 5:20 PM
$KZR adding some here
0 · Reply
Adrianople117
Adrianople117 Oct. 21 at 1:46 AM
$KZR alot of sell orders and price hasnt dropped. Usually means institutions selling. Stock is at 6.09 after hours. My opinion we will see 4 bucks in less than a couple weeks. Sure they had 90.1 m in sept but another clinical trial re do is expensive. And they burn 4m a month without the clinical trial costs.
0 · Reply
Raxothus
Raxothus Oct. 20 at 7:48 PM
EOD CONTINUATION FOLLOW-UP – 10/17/25 Tracking continuation watchlist from yesterday based on intraday highs vs. close ❌ $SPAI – Dropped from 9.00 to 7.38 (–18%), full fade after strong prior session. Failed continuation. ⚠️ $KZR – Moving sideways, no clear trend. Neutral. ✅ $DMRC – Closed 8.60, hit HOD 9.27 (+7.8%), solid continuation with controlled pullback. ✅ $SGHT – Closed 4.60, reached 5.14 (+11.7%), clean follow-through, strong intraday action. ✅ $VANI – Closed 1.70, now 1.83 (+7.6%), gradual continuation move. Recap: 5 total → 3 winners ($DMRC, $SGHT, $VANI), 1 fail ($SPAI), 1 neutral → 60% accuracy Leaders: $SGHT showed strongest continuation, $DMRC and $VANI held structure well; $SPAI was the only full fade. #vwap #smallcaps #daytrading #eodfollowup #continuation #snipersetup #accountability
0 · Reply
topstockalerts
topstockalerts Oct. 20 at 12:00 PM
$KZR where's it going once market opens?
0 · Reply
ChartChartist
ChartChartist Oct. 19 at 6:33 PM
$PCSA crypto play $KZR wow, missed that $AREB long hold is perfected $OMEX bullish $BCG massive Asset Mgmt company , 2.8m float , $2.20 bottom gonna rocket be in first !
0 · Reply
Latest News on KZR
Kezar Life Sciences Announces 1-for-10 Reverse Stock Split

Oct 28, 2024, 8:30 AM EDT - 1 year ago

Kezar Life Sciences Announces 1-for-10 Reverse Stock Split


Kezar Life Sciences halts mid-stage trial for lupus treatment

Sep 30, 2024, 8:46 AM EDT - 1 year ago

Kezar Life Sciences halts mid-stage trial for lupus treatment


Kezar Life Sciences to Host Virtual R&D Day on March 22, 2023

Mar 6, 2023, 7:00 AM EST - 2 years ago

Kezar Life Sciences to Host Virtual R&D Day on March 22, 2023


d_risk
d_risk Nov. 12 at 10:28 PM
$KZR - Kezar Life Sciences, Inc. - 10Q - Updated Risk Factors KZR’s latest 10-Q risk factors expand on capital needs, clinical trial and regulatory hurdles, strategic alternatives, restructuring uncertainties, IP and patent challenges, executive retention, cybersecurity, global volatility, concentrated ownership, and new compliance and anti-takeover risks. #Biotechnology #Cybersecurity #CapitalNeeds #RegulatoryRisk #ClinicalTrials 🟢 Added 🟠 Removed https://d-risk.ai/KZR/10-Q/2025-11-12
0 · Reply
Adrianople117
Adrianople117 Nov. 7 at 9:58 PM
$KZR possibly.... we will see with earnings how much cash they have now.
0 · Reply
Maddmike
Maddmike Nov. 7 at 9:06 PM
$KZR back to$5 🤔
0 · Reply
Adrianople117
Adrianople117 Nov. 4 at 6:28 PM
$KZR hmmm....
0 · Reply
Adrianople117
Adrianople117 Oct. 31 at 4:27 AM
$KZR hmmm.... first its ever dropped below 6... well have to see during market open what happens... curious
0 · Reply
brj1323
brj1323 Oct. 24 at 5:20 PM
$KZR adding some here
0 · Reply
Adrianople117
Adrianople117 Oct. 21 at 1:46 AM
$KZR alot of sell orders and price hasnt dropped. Usually means institutions selling. Stock is at 6.09 after hours. My opinion we will see 4 bucks in less than a couple weeks. Sure they had 90.1 m in sept but another clinical trial re do is expensive. And they burn 4m a month without the clinical trial costs.
0 · Reply
Raxothus
Raxothus Oct. 20 at 7:48 PM
EOD CONTINUATION FOLLOW-UP – 10/17/25 Tracking continuation watchlist from yesterday based on intraday highs vs. close ❌ $SPAI – Dropped from 9.00 to 7.38 (–18%), full fade after strong prior session. Failed continuation. ⚠️ $KZR – Moving sideways, no clear trend. Neutral. ✅ $DMRC – Closed 8.60, hit HOD 9.27 (+7.8%), solid continuation with controlled pullback. ✅ $SGHT – Closed 4.60, reached 5.14 (+11.7%), clean follow-through, strong intraday action. ✅ $VANI – Closed 1.70, now 1.83 (+7.6%), gradual continuation move. Recap: 5 total → 3 winners ($DMRC, $SGHT, $VANI), 1 fail ($SPAI), 1 neutral → 60% accuracy Leaders: $SGHT showed strongest continuation, $DMRC and $VANI held structure well; $SPAI was the only full fade. #vwap #smallcaps #daytrading #eodfollowup #continuation #snipersetup #accountability
0 · Reply
topstockalerts
topstockalerts Oct. 20 at 12:00 PM
$KZR where's it going once market opens?
0 · Reply
ChartChartist
ChartChartist Oct. 19 at 6:33 PM
$PCSA crypto play $KZR wow, missed that $AREB long hold is perfected $OMEX bullish $BCG massive Asset Mgmt company , 2.8m float , $2.20 bottom gonna rocket be in first !
0 · Reply
PaulLaurent
PaulLaurent Oct. 19 at 5:06 PM
🌅 4:00am EST Watchlist $SLS – New SEC report with corporate updates and cap-structure housekeeping. Focus on GPS (WT1) across prioritized indications. Watch next clinical milestones, partnering color, and cash runway disclosures that could frame Q4 catalysts. $VIVK – Multiple SEC updates following the $40M commodity intermediation term sheet. Track conversion to definitive docs, initial draws/use of proceeds, revenue ramp cadence, and any Nasdaq compliance implications. $KZR – Potential multi-day runner. Monitor premarket volume, VWAP reclaims, and prior HOD retests. $RANI – Potential multi-day runner. Look for higher-low structure, liquidity expansion, and tight risk on fades. $SLNH – Potential multi-day runner. Favor clean pullbacks to VWAP and momentum continuation. Tone: Filings and financing paths set the narrative. Favor VWAP/pivot reclaims, trim into strength, keep risk tight.
0 · Reply
strongii
strongii Oct. 19 at 3:40 PM
0 · Reply
AnalyticaInvestor
AnalyticaInvestor Oct. 19 at 12:38 PM
$GWH $ARTV $KZR $NUAI $CREV While everyone is chasing $GOLD and $SILVER, $KCP.V is preparing to drill one of the most under-the-radar copper targets in South America. ▸ Surrounded by major copper mines ▸ Fully funded 15,000m program ▸ Deep porphyry targets untouched ▸ Led by Oyu Tolgoi co-discoverer Doug Kirwin This could be the next major re-rate story in copper. Read the full breakdown here 👇 https://analyticainvestor.beehiiv.com/p/while-the-market-chased-metals-one-junior-quietly-positioned-for-a-breakout
0 · Reply
StockScanners
StockScanners Oct. 18 at 3:55 PM
$KZR keep watch if this holds above 5.75
0 · Reply
TheStockSquatch
TheStockSquatch Oct. 18 at 1:02 PM
$CREV Nice hit... $KZR Congrats to those holding. Nice! $COOT Hell yeah! Was in @.62 - I sold too early. Oh well... $BCG This is getting warmed up! Looks ready! Still adding...
0 · Reply
topstockalerts
topstockalerts Oct. 18 at 12:56 PM
Fridays Top Gainers $RANI $ARTV $KZR $NUAI $CREV
0 · Reply
TraderJay85
TraderJay85 Oct. 18 at 3:54 AM
$KZR Got the team in. can we see 7.90
0 · Reply
popsallen
popsallen Oct. 18 at 3:22 AM
$RANI great news, better move today - I don't think she's done! $KZR Holding it's gains AH - let's see what monday brings $CREV Needs to break 5.40! $BCG Awesome move AH! The chart is screaming for new highs. $4-5 next week when volume really hits
0 · Reply
Social_Idiot
Social_Idiot Oct. 18 at 3:01 AM
$PLX Look at $KZR ... Bad news and it jumps up 52%. Really, I can't see what would be good for KZR right now. Manipulation on low float penny trading or hostile takeover of assets...?
2 · Reply
Adrianople117
Adrianople117 Oct. 18 at 2:42 AM
$KZR Tang capital that the CEO mentioned tried to acquire them at 1.10 a share was refused and than they ensured Tang couldnt do a hostile takeover. I doubt they would pay more for a company that is looking for every alternative to cut costs and lay offs. Quite the different company from 2024.
0 · Reply
Adrianople117
Adrianople117 Oct. 18 at 1:46 AM
$KZR Putting a put down. These guys have nothing. Theyre grasping at straws. CEO knows they are done. They cant raise capital if the stock is back to 1 dollar. Dillution i feel is incoming. Otherwise why spam the news section with promises of mergers or sale. I can see them selling their last pipeline and all the rights to it. Its what happened to ADAP. And now its a 0.20 cent pump and dump stock again.
1 · Reply
AlphaEdge777
AlphaEdge777 Oct. 17 at 11:25 PM
$KZR 4.24$ to 6.59$, great for the bulls! Next one on the list: VRME closing strong and running to 1.33$ after hours 📈 ✅ Golden cross ✅ Compliance PR ✅ Treasury catalysts 👀The market’s catching on
0 · Reply